<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39316623</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS biology</Title><ISOAbbreviation>PLoS Biol</ISOAbbreviation></Journal><ArticleTitle>A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.</ArticleTitle><Pagination><StartPage>e3002767</StartPage><MedlinePgn>e3002767</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3002767</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.3002767</ELocationID><Abstract><AbstractText>Interferons (IFNs) play a crucial role in the regulation and evolution of host-virus interactions. Here, we conducted a genome-wide arrayed CRISPR knockout screen in the presence and absence of IFN to identify human genes that influence Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. We then performed an integrated analysis of genes interacting with SARS-CoV-2, drawing from a selection of 67 large-scale studies, including our own. We identified 28 genes of high relevance in both human genetic studies of Coronavirus Disease 2019 (COVID-19) patients and functional genetic screens in cell culture, with many related to the IFN pathway. Among these was the IFN-stimulated gene PLSCR1. PLSCR1 did not require IFN induction to restrict SARS-CoV-2 and did not contribute to IFN signaling. Instead, PLSCR1 specifically restricted spike-mediated SARS-CoV-2 entry. The PLSCR1-mediated restriction was alleviated by TMPRSS2 overexpression, suggesting that PLSCR1 primarily restricts the endocytic entry route. In addition, recent SARS-CoV-2 variants have adapted to circumvent the PLSCR1 barrier via currently undetermined mechanisms. Finally, we investigate the functional effects of PLSCR1 variants present in humans and discuss an association between PLSCR1 and severe COVID-19 reported recently.</AbstractText><CopyrightInformation>Copyright: © 2024 Le Pen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le Pen</LastName><ForeName>Jérémie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7025-9526</Identifier><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paniccia</LastName><ForeName>Gabrielle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinast</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Virology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moncada-Velez</LastName><ForeName>Marcela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashbrook</LastName><ForeName>Alison W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>H-Heinrich</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinharanda</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Columbia University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricardo-Lax</LastName><ForeName>Inna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenzel</LastName><ForeName>Ansgar F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosado-Olivieri</LastName><ForeName>Edwin A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Laboratory of Synthetic Embryology, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinnon</LastName><ForeName>Kenneth H</ForeName><Initials>KH</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doyle</LastName><ForeName>William C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freije</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Seon-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Danyel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Cité University, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewy</LastName><ForeName>Tyler</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peace</LastName><ForeName>Avery</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Carltin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>William M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Roni</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Elaine Z</ForeName><Initials>EZ</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fisher Drug Discovery Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGinn</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fisher Drug Discovery Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Miriam-Rose</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Fisher Drug Discovery Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Espiritu</LastName><ForeName>Lavoisier</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fisher Drug Discovery Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Priyam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bio-Imaging Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poirier</LastName><ForeName>John T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sànchez-Rivera</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobat</LastName><ForeName>Aurélie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Cité University, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Cité University, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casanova</LastName><ForeName>Jean-Laurent</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Cité University, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Necker Hospital for Sick Children, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Bioinformatics Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glickman</LastName><ForeName>J Fraser</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Fisher Drug Discovery Resource Center, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michailidis</LastName><ForeName>Eleftherios</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razooky</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Margaret R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Charles M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI091707</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI111825</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI163029</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI161444</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C062010">leu-13 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="C421305">TMPRSS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D012697">Serine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000943">Antigens, Differentiation</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012697" MajorTopicYN="N">Serine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064112" MajorTopicYN="N">Clustered Regularly Interspaced Short Palindromic Repeats</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000943" MajorTopicYN="N">Antigens, Differentiation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39316623</ArticleId><ArticleId IdType="pmc">PMC11486371</ArticleId><ArticleId IdType="doi">10.1371/journal.pbio.3002767</ArticleId><ArticleId IdType="pii">PBIOLOGY-D-24-00510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Le Pen J, Rice CM. The antiviral state of the cell: lessons from SARS-CoV-2. Curr Opin Immunol. 2024;87:102426. Epub 20240523. doi: 10.1016/j.coi.2024.102426 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2024.102426</ArticleId><ArticleId IdType="pmc">PMC11260430</ArticleId><ArticleId IdType="pubmed">38795501</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Zhang Q, Zhang SY, Jouanguy E, Casanova JL. Type I interferons and SARS-CoV-2: from cells to organisms. Curr Opin Immunol. 2022;74:172–182. Epub 20220125. doi: 10.1016/j.coi.2022.01.003 ; PubMed Central PMCID: PMC8786610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8786610</ArticleId><ArticleId IdType="pubmed">35149239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al.. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6(62). Epub 2021/08/21. doi: 10.1126/sciimmunol.abl4340 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, et al.. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021;218(10). Epub 20210806. doi: 10.1084/jem.20211211 ; PubMed Central PMCID: PMC8352718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211211</ArticleId><ArticleId IdType="pmc">PMC8352718</ArticleId><ArticleId IdType="pubmed">34357402</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, et al.. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6(62). doi: 10.1126/sciimmunol.abl4348 ; PubMed Central PMCID: PMC8532080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4348</ArticleId><ArticleId IdType="pmc">PMC8532080</ArticleId><ArticleId IdType="pubmed">34413140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al.. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515). Epub 20200924. doi: 10.1126/science.abd4570 ; PubMed Central PMCID: PMC7857407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al.. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515). Epub 20200924. doi: 10.1126/science.abd4585 ; PubMed Central PMCID: PMC7857397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Matuozzo D, Le Pen J, Lee D, Moens L, Asano T, et al.. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J Exp Med. 2022;219(8). Epub 20220616. doi: 10.1084/jem.20220131 ; PubMed Central PMCID: PMC9206114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220131</ArticleId><ArticleId IdType="pmc">PMC9206114</ArticleId><ArticleId IdType="pubmed">35708626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. Epub 20200203. doi: 10.1038/s41586-020-2012-7 ; PubMed Central PMCID: PMC7095418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Savan R, Gale M Jr., Innate immunity and interferon in SARS-CoV-2 infection outcome. Immunity. 2023;56(7):1443–1450. doi: 10.1016/j.immuni.2023.06.018 ; PubMed Central PMCID: PMC10361255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2023.06.018</ArticleId><ArticleId IdType="pmc">PMC10361255</ArticleId><ArticleId IdType="pubmed">37437537</ArticleId></ArticleIdList></Reference><Reference><Citation>Danziger O, Patel RS, DeGrace EJ, Rosen MR, Rosenberg BR. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor. PLoS Pathog. 2022;18(4):e1010464. Epub 20220414. doi: 10.1371/journal.ppat.1010464 ; PubMed Central PMCID: PMC9041830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010464</ArticleId><ArticleId IdType="pmc">PMC9041830</ArticleId><ArticleId IdType="pubmed">35421191</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Sancho L, Lewinski MK, Pache L, Stoneham CA, Yin X, Becker ME, et al.. Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell. 2021;81(12):2656–2668 e8. Epub 20210413. doi: 10.1016/j.molcel.2021.04.008 ; PubMed Central PMCID: PMC8043580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8043580</ArticleId><ArticleId IdType="pubmed">33930332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickenhagen A, Sugrue E, Lytras S, Kuchi S, Noerenberg M, Turnbull ML, et al.. A prenylated dsRNA sensor protects against severe COVID-19. Science. 2021;374(6567):eabj3624. Epub 20211029. doi: 10.1126/science.abj3624 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj3624</ArticleId><ArticleId IdType="pmc">PMC7612834</ArticleId><ArticleId IdType="pubmed">34581622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R, Case JB, Yutuc E, Ma X, Shen S, Gomez Castro MF, et al.. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proc Natl Acad Sci U S A. 2020;117(50):32105–32113. Epub 20201125. doi: 10.1073/pnas.2012197117 ; PubMed Central PMCID: PMC7749331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2012197117</ArticleId><ArticleId IdType="pmc">PMC7749331</ArticleId><ArticleId IdType="pubmed">33239446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur R, Tada T, Landau NR. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4). MBio. 2023;14(4):e0109023. Epub 20230629. doi: 10.1128/mbio.01090-23 ; PubMed Central PMCID: PMC10470548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.01090-23</ArticleId><ArticleId IdType="pmc">PMC10470548</ArticleId><ArticleId IdType="pubmed">37382452</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al.. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481–485. Epub 20110410. doi: 10.1038/nature09907 ; PubMed Central PMCID: PMC3409588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09907</ArticleId><ArticleId IdType="pmc">PMC3409588</ArticleId><ArticleId IdType="pubmed">21478870</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins JW. Interferon-Stimulated Genes: What Do They All Do? Annu Rev Virol. 2019;6(1):567–584. Epub 2019/07/10. doi: 10.1146/annurev-virology-092818-015756 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092818-015756</ArticleId><ArticleId IdType="pubmed">31283436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, et al.. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen. Nat Commun. 2022;13(1):2442. Epub 20220504. doi: 10.1038/s41467-022-30134-9 ; PubMed Central PMCID: PMC9068693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30134-9</ArticleId><ArticleId IdType="pmc">PMC9068693</ArticleId><ArticleId IdType="pubmed">35508460</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Jiang W, Wu L, Gaudet RG, Park ES, Su M, et al.. PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection. Nature. 2023;619(7971):819–827. Epub 20230712. doi: 10.1038/s41586-023-06322-y ; PubMed Central PMCID: PMC10371867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06322-y</ArticleId><ArticleId IdType="pmc">PMC10371867</ArticleId><ArticleId IdType="pubmed">37438530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS, Lee K, Kim SJ, Cho S, Shin HJ, Kim C, et al.. Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection. Genome Res. 2018;28(6):859–868. Epub 20180430. doi: 10.1101/gr.230250.117 ; PubMed Central PMCID: PMC5991512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.230250.117</ArticleId><ArticleId IdType="pmc">PMC5991512</ArticleId><ArticleId IdType="pubmed">29712754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross BC, Lawo S, Archer CR, Hunt JR, Yarker JL, Riccombeni A, et al.. Increasing the performance of pooled CRISPR-Cas9 drop-out screening. Sci Rep. 2016;6:31782. Epub 20160822. doi: 10.1038/srep31782 ; PubMed Central PMCID: PMC4992892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31782</ArticleId><ArticleId IdType="pmc">PMC4992892</ArticleId><ArticleId IdType="pubmed">27545104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodigepalli KM, Bowers K, Sharp A, Nanjundan M. Roles and regulation of phospholipid scramblases. FEBS Lett. 2015;589(1):3–14. Epub 20141203. doi: 10.1016/j.febslet.2014.11.036 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.11.036</ArticleId><ArticleId IdType="pubmed">25479087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 1997;272(29):18240–18244. doi: 10.1074/jbc.272.29.18240 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.29.18240</ArticleId><ArticleId IdType="pubmed">9218461</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong B, Zhou Q, Zhao J, Zhou A, Harty RN, Bose S, et al.. Phospholipid scramblase 1 potentiates the antiviral activity of interferon. J Virol. 2004;78(17):8983–8993. doi: 10.1128/JVI.78.17.8983-8993.2004 ; PubMed Central PMCID: PMC506946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.17.8983-8993.2004</ArticleId><ArticleId IdType="pmc">PMC506946</ArticleId><ArticleId IdType="pubmed">15308695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, et al.. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023;617(7962):764–768. Epub 20230517. doi: 10.1038/s41586-023-06034-3 ; PubMed Central PMCID: PMC10208981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06034-3</ArticleId><ArticleId IdType="pmc">PMC10208981</ArticleId><ArticleId IdType="pubmed">37198478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, et al.. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607(7917):97–103. Epub 20220307. doi: 10.1038/s41586-022-04576-6 ; PubMed Central PMCID: PMC9259496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04576-6</ArticleId><ArticleId IdType="pmc">PMC9259496</ArticleId><ArticleId IdType="pubmed">35255492</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Vanstreels E, Jansen S, Daelemans D. Cellular host factors for SARS-CoV-2 infection. Nat Microbiol. 2021;6(10):1219–1232. Epub 20210901. doi: 10.1038/s41564-021-00958-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00958-0</ArticleId><ArticleId IdType="pubmed">34471255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann HH, Sanchez-Rivera FJ, Schneider WM, Luna JM, Soto-Feliciano YM, Ashbrook AW, et al.. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. Cell Host Microbe. 2021;29(2):267–280 e5. Epub 20201216. doi: 10.1016/j.chom.2020.12.009 ; PubMed Central PMCID: PMC7833927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7833927</ArticleId><ArticleId IdType="pubmed">33357464</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, et al.. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020;182(5):1284–1294 e9. Epub 20200717. doi: 10.1016/j.cell.2020.07.012 ; PubMed Central PMCID: PMC7366990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.012</ArticleId><ArticleId IdType="pmc">PMC7366990</ArticleId><ArticleId IdType="pubmed">32730807</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, et al.. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020;586(7827):113–119. Epub 20200724. doi: 10.1038/s41586-020-2577-1 ; PubMed Central PMCID: PMC7603405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2577-1</ArticleId><ArticleId IdType="pmc">PMC7603405</ArticleId><ArticleId IdType="pubmed">32707573</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider WM, Luna JM, Hoffmann HH, Sanchez-Rivera FJ, Leal AA, Ashbrook AW, et al.. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks. Cell. 2021;184(1):120–132 e14. Epub 20201209. doi: 10.1016/j.cell.2020.12.006 ; PubMed Central PMCID: PMC7796900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7796900</ArticleId><ArticleId IdType="pubmed">33382968</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, Lan Q, Su S, Wang X, Xu W, Liu Z, et al.. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct Target Ther. 2020;5(1):92. Epub 20200612. doi: 10.1038/s41392-020-0184-0 ; PubMed Central PMCID: PMC7289711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0184-0</ArticleId><ArticleId IdType="pmc">PMC7289711</ArticleId><ArticleId IdType="pubmed">32532959</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, et al.. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30(4):343–355. Epub 20200330. doi: 10.1038/s41422-020-0305-x ; PubMed Central PMCID: PMC7104723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0305-x</ArticleId><ArticleId IdType="pmc">PMC7104723</ArticleId><ArticleId IdType="pubmed">32231345</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Rev Med Virol. 2020;30(3):e2106. Epub 20200417. doi: 10.1002/rmv.2106 ; PubMed Central PMCID: PMC7235496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2106</ArticleId><ArticleId IdType="pmc">PMC7235496</ArticleId><ArticleId IdType="pubmed">32302058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumpter R, Jr., Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al.. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I J Virol. 2005;79(5):2689–2699. doi: 10.1128/JVI.79.5.2689-2699.2005 ; PubMed Central PMCID: PMC548482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.5.2689-2699.2005</ArticleId><ArticleId IdType="pmc">PMC548482</ArticleId><ArticleId IdType="pubmed">15708988</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, et al.. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020;117(13):7001–7003. Epub 20200312. doi: 10.1073/pnas.2002589117 ; PubMed Central PMCID: PMC7132130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002589117</ArticleId><ArticleId IdType="pmc">PMC7132130</ArticleId><ArticleId IdType="pubmed">32165541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al.. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271–280 e8. Epub 20200305. doi: 10.1016/j.cell.2020.02.052 ; PubMed Central PMCID: PMC7102627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3–20. Epub 20211005. doi: 10.1038/s41580-021-00418-x ; PubMed Central PMCID: PMC8491763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and biological functions. J Biol Chem. 2007;282(28):20053–20057. Epub 20070514. doi: 10.1074/jbc.R700006200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R700006200</ArticleId><ArticleId IdType="pubmed">17502368</ArticleId></ArticleIdList></Reference><Reference><Citation>de Weerd NA, Nguyen T. The interferons and their receptors--distribution and regulation. Immunol Cell Biol. 2012;90(5):483–491. Epub 20120313. doi: 10.1038/icb.2012.9 ; PubMed Central PMCID: PMC7165917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2012.9</ArticleId><ArticleId IdType="pmc">PMC7165917</ArticleId><ArticleId IdType="pubmed">22410872</ArticleId></ArticleIdList></Reference><Reference><Citation>Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol. 2007;316:71–95. doi: 10.1007/978-3-540-71329-6_5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-71329-6_5</ArticleId><ArticleId IdType="pubmed">17969444</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16(7):423–439. doi: 10.1038/s41579-018-0020-5 ; PubMed Central PMCID: PMC7097117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0020-5</ArticleId><ArticleId IdType="pmc">PMC7097117</ArticleId><ArticleId IdType="pubmed">29769653</ArticleId></ArticleIdList></Reference><Reference><Citation>Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, et al.. ISG15 deficiency and increased viral resistance in humans but not mice. Nat Commun. 2016;7:11496. Epub 20160519. doi: 10.1038/ncomms11496 ; PubMed Central PMCID: PMC4873964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11496</ArticleId><ArticleId IdType="pmc">PMC4873964</ArticleId><ArticleId IdType="pubmed">27193971</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, et al.. Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature. 2015;517(7532):89–93. Epub 20141012. doi: 10.1038/nature13801 ; PubMed Central PMCID: PMC4303590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13801</ArticleId><ArticleId IdType="pmc">PMC4303590</ArticleId><ArticleId IdType="pubmed">25307056</ArticleId></ArticleIdList></Reference><Reference><Citation>Malakhova OA, Kim KI, Luo JK, Zou W, Kumar KG, Fuchs SY, et al.. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 2006;25(11):2358–2367. Epub 20060518. doi: 10.1038/sj.emboj.7601149 ; PubMed Central PMCID: PMC1478183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601149</ArticleId><ArticleId IdType="pmc">PMC1478183</ArticleId><ArticleId IdType="pubmed">16710296</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, Monneron D, Pichard-Garcia L, Piehler J, et al.. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response. PLoS ONE. 2011;6(7):e22200. Epub 20110714. doi: 10.1371/journal.pone.0022200 ; PubMed Central PMCID: PMC3136508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022200</ArticleId><ArticleId IdType="pmc">PMC3136508</ArticleId><ArticleId IdType="pubmed">21779393</ArticleId></ArticleIdList></Reference><Reference><Citation>Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al.. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603–607. Epub 20120328. doi: 10.1038/nature11003 ; PubMed Central PMCID: PMC3320027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11003</ArticleId><ArticleId IdType="pmc">PMC3320027</ArticleId><ArticleId IdType="pubmed">22460905</ArticleId></ArticleIdList></Reference><Reference><Citation>Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H, et al.. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol. 2015;33(3):306–312. Epub 20141208. doi: 10.1038/nbt.3080 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3080</ArticleId><ArticleId IdType="pubmed">25485619</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GT. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348(6235):648–660. Epub 20150507. doi: 10.1126/science.1262110 ; PubMed Central PMCID: PMC4547484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1262110</ArticleId><ArticleId IdType="pmc">PMC4547484</ArticleId><ArticleId IdType="pubmed">25954001</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath CM, Stark GR, Kerr IM, Darnell JE Jr., Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol Cell Biol. 1996;16(12):6957–6964. doi: 10.1128/mcb.16.12.6957 ; PubMed Central PMCID: PMC231699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.16.12.6957</ArticleId><ArticleId IdType="pmc">PMC231699</ArticleId><ArticleId IdType="pubmed">8943351</ArticleId></ArticleIdList></Reference><Reference><Citation>Veals SA, Schindler C, Leonard D, Fu XY, Aebersold R, Darnell JE, Jr., et al.. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol. 1992;12(8):3315–3324. doi: 10.1128/mcb.12.8.3315-3324.1992 ; PubMed Central PMCID: PMC364572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.12.8.3315-3324.1992</ArticleId><ArticleId IdType="pmc">PMC364572</ArticleId><ArticleId IdType="pubmed">1630447</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell JE, Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264(5164):1415–1421. doi: 10.1126/science.8197455 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8197455</ArticleId><ArticleId IdType="pubmed">8197455</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler C, Strehlow I. Cytokines and STAT signaling. Adv Pharmacol. 2000;47:113–174. doi: 10.1016/s1054-3589(08)60111-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1054-3589(08)60111-8</ArticleId><ArticleId IdType="pubmed">10582086</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy DE, Darnell JE Jr., Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651–662. doi: 10.1038/nrm909 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm909</ArticleId><ArticleId IdType="pubmed">12209125</ArticleId></ArticleIdList></Reference><Reference><Citation>Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, et al.. Structure and function of a new STAT-induced STAT inhibitor. Nature. 1997;387(6636):924–929. doi: 10.1038/43219 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/43219</ArticleId><ArticleId IdType="pubmed">9202127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al.. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020;181(5):1016–1035 e19. Epub 20200427. doi: 10.1016/j.cell.2020.04.035 ; PubMed Central PMCID: PMC7252096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Onabajo OO, Banday AR, Stanifer ML, Yan W, Obajemu A, Santer DM, et al.. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet. 2020;52(12):1283–1293. Epub 20201019. doi: 10.1038/s41588-020-00731-9 ; PubMed Central PMCID: PMC9377523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00731-9</ArticleId><ArticleId IdType="pmc">PMC9377523</ArticleId><ArticleId IdType="pubmed">33077916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao MM, Yang WL, Yang FY, Zhang L, Huang WJ, Hou W, et al.. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021;6(1):134. Epub 20210327. doi: 10.1038/s41392-021-00558-8 ; PubMed Central PMCID: PMC7997800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00558-8</ArticleId><ArticleId IdType="pmc">PMC7997800</ArticleId><ArticleId IdType="pubmed">33774649</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al.. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117(21):11727–11734. Epub 20200506. doi: 10.1073/pnas.2003138117 ; PubMed Central PMCID: PMC7260975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Luo S, Libby P, Shi GP. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacol Ther. 2020;213:107587. Epub 20200526. doi: 10.1016/j.pharmthera.2020.107587 ; PubMed Central PMCID: PMC7255230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107587</ArticleId><ArticleId IdType="pmc">PMC7255230</ArticleId><ArticleId IdType="pubmed">32470470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini S, John J, Shearer M, Kerr IM, Stark GR. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol Cell Biol. 1989;9(11):4605–4612. doi: 10.1128/mcb.9.11.4605-4612.1989 ; PubMed Central PMCID: PMC363606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.9.11.4605-4612.1989</ArticleId><ArticleId IdType="pmc">PMC363606</ArticleId><ArticleId IdType="pubmed">2513475</ArticleId></ArticleIdList></Reference><Reference><Citation>Velazquez L, Fellous M, Stark GR, Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell. 1992;70(2):313–322. doi: 10.1016/0092-8674(92)90105-l .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90105-l</ArticleId><ArticleId IdType="pubmed">1386289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li W, Hui H, Tiwari SK, Zhang Q, Croker BA, et al.. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39(21):e106057. Epub 20201005. doi: 10.15252/embj.2020106057 ; PubMed Central PMCID: PMC7537045.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106057</ArticleId><ArticleId IdType="pmc">PMC7537045</ArticleId><ArticleId IdType="pubmed">32944968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Feng F, Hu G, Wang Y, Yu Y, Zhu Y, et al.. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. Nat Commun. 2021;12(1):961. Epub 20210211. doi: 10.1038/s41467-021-21213-4 ; PubMed Central PMCID: PMC7878750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21213-4</ArticleId><ArticleId IdType="pmc">PMC7878750</ArticleId><ArticleId IdType="pubmed">33574281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei LH, Sun Y, Guo JU. Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed -1 ribosomal frameshifting. Cell Rep. 2023;42(8):112987. Epub 20230814. doi: 10.1016/j.celrep.2023.112987 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112987</ArticleId><ArticleId IdType="pubmed">37581984</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Alfajaro MM, DeWeirdt PC, Hanna RE, Lu-Culligan WJ, Cai WL, et al.. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection. Cell. 2021;184(1):76–91 e13. Epub 20201020. doi: 10.1016/j.cell.2020.10.028 ; PubMed Central PMCID: PMC7574718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.028</ArticleId><ArticleId IdType="pmc">PMC7574718</ArticleId><ArticleId IdType="pubmed">33147444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, Travisano KA, Hayashi JM, et al.. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Cell. 2021;184(1):106–119 e14. Epub 20201209. doi: 10.1016/j.cell.2020.12.004 ; PubMed Central PMCID: PMC7723770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7723770</ArticleId><ArticleId IdType="pubmed">33333024</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Chow RD, Pena-Hernandez MA, Zhang L, Loeb SA, So EY, et al.. LRRC15 inhibits SARS-CoV-2 cellular entry in trans. PLoS Biol. 2022;20(10):e3001805. Epub 20221013. doi: 10.1371/journal.pbio.3001805 ; PubMed Central PMCID: PMC9595563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001805</ArticleId><ArticleId IdType="pmc">PMC9595563</ArticleId><ArticleId IdType="pubmed">36228039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MS, Kerkvliet JG, Hoppe AD. Whole genome CRISPR screening strategy to identify genes contributing to SARS-CoV-2 spike and VSV-G mediated entry. J Med Virol. 2023;95(9):e29087. doi: 10.1002/jmv.29087 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29087</ArticleId><ArticleId IdType="pubmed">37707319</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehfeld F, Eitson JL, Ohlson MB, Chang TC, Schoggins JW, Mendell JT. CRISPR screening reveals a dependency on ribosome recycling for efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication. Cell Rep. 2023;42(2):112076. Epub 20230130. doi: 10.1016/j.celrep.2023.112076 ; PubMed Central PMCID: PMC9884621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112076</ArticleId><ArticleId IdType="pmc">PMC9884621</ArticleId><ArticleId IdType="pubmed">36753415</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebendenne A, Roy P, Bonaventure B, Chaves Valadao AL, Desmarets L, Arnaud-Arnould M, et al.. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. Nat Genet. 2022;54(8):1090–1102. Epub 20220725. doi: 10.1038/s41588-022-01110-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01110-2</ArticleId><ArticleId IdType="pubmed">35879413</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahmeier F, Lavacca TM, Goellner S, Neufeldt CJ, Prasad V, Cerikan B, et al.. Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis. J Virol. 2023:e0087823. Epub 20231031. doi: 10.1128/jvi.00878-23 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00878-23</ArticleId><ArticleId IdType="pmc">PMC10688318</ArticleId><ArticleId IdType="pubmed">37905840</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo L, Waller MA, Moreno CL, Cole AJ, Stella AO, Pop OT, et al.. Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs. PLoS Biol. 2023;21(2):e3001967. Epub 20230209. doi: 10.1371/journal.pbio.3001967 ; PubMed Central PMCID: PMC9910744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001967</ArticleId><ArticleId IdType="pmc">PMC9910744</ArticleId><ArticleId IdType="pubmed">36757924</ArticleId></ArticleIdList></Reference><Reference><Citation>Israeli M, Finkel Y, Yahalom-Ronen Y, Paran N, Chitlaru T, Israeli O, et al.. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2. Nat Commun. 2022;13(1):2237. Epub 20220425. doi: 10.1038/s41467-022-29896-z ; PubMed Central PMCID: PMC9039069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29896-z</ArticleId><ArticleId IdType="pmc">PMC9039069</ArticleId><ArticleId IdType="pubmed">35469023</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodzki M, Bluhm AP, Schaefer M, Tagmount A, Russo M, Sobh A, et al.. Genome-scale CRISPR screens identify host factors that promote human coronavirus infection. Genome Med. 2022;14(1):10. Epub 20220127. doi: 10.1186/s13073-022-01013-1 ; PubMed Central PMCID: PMC8792531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01013-1</ArticleId><ArticleId IdType="pmc">PMC8792531</ArticleId><ArticleId IdType="pubmed">35086559</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, et al.. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370(6521). Epub 20201015. doi: 10.1126/science.abe9403 ; PubMed Central PMCID: PMC7808408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9403</ArticleId><ArticleId IdType="pmc">PMC7808408</ArticleId><ArticleId IdType="pubmed">33060197</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniloski Z, Jordan TX, Wessels HH, Hoagland DA, Kasela S, Legut M, et al.. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell. 2021;184(1):92–105 e16. Epub 20201024. doi: 10.1016/j.cell.2020.10.030 ; PubMed Central PMCID: PMC7584921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.030</ArticleId><ArticleId IdType="pmc">PMC7584921</ArticleId><ArticleId IdType="pubmed">33147445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K, Farias AG, Lee H, Guvenc F, Mero P, Brown KR, et al.. Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors. Heliyon. 2023;9(1):e12744. Epub 20221230. doi: 10.1016/j.heliyon.2022.e12744 ; PubMed Central PMCID: PMC9800021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e12744</ArticleId><ArticleId IdType="pmc">PMC9800021</ArticleId><ArticleId IdType="pubmed">36597481</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering SB, Sarnik SA, Wang E, Zengel JR, Leist SR, Schafer A, et al.. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection. Nat Genet. 2022;54(8):1078–1089. Epub 20220725. doi: 10.1038/s41588-022-01131-x ; PubMed Central PMCID: PMC9355872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01131-x</ArticleId><ArticleId IdType="pmc">PMC9355872</ArticleId><ArticleId IdType="pubmed">35879412</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Persoons L, Vanstreels E, Jansen S, Van Looveren D, Boeckx B, et al.. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat Genet. 2021;53(4):435–444. Epub 20210308. doi: 10.1038/s41588-021-00805-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00805-2</ArticleId><ArticleId IdType="pubmed">33686287</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al.. Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA. 2020;324(7):663–673. doi: 10.1001/jama.2020.13719 ; PubMed Central PMCID: PMC7382021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13719</ArticleId><ArticleId IdType="pmc">PMC7382021</ArticleId><ArticleId IdType="pubmed">32706371</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton JF, Shastri AJ, Ye C, Weldon CH, Filshtein-Sonmez T, Coker D, et al.. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat Genet. 2021;53(6):801–808. Epub 20210422. doi: 10.1038/s41588-021-00854-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00854-7</ArticleId><ArticleId IdType="pubmed">33888907</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts GHL, Partha R, Rhead B, Knight SC, Park DS, Coignet MV, et al.. Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects. Nat Genet. 2022;54(4):374–381. Epub 20220411. doi: 10.1038/s41588-022-01042-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01042-x</ArticleId><ArticleId IdType="pubmed">35410379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, Chua RL, Wheeler E, Jechow K, Willett JDS, Radbruch H, et al.. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19. Nat Commun. 2022;13(1):4484. Epub 20220815. doi: 10.1038/s41467-022-31999-6 ; PubMed Central PMCID: PMC9378714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31999-6</ArticleId><ArticleId IdType="pmc">PMC9378714</ArticleId><ArticleId IdType="pubmed">35970849</ArticleId></ArticleIdList></Reference><Reference><Citation>Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P, et al.. COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells. Genes (Basel). 2020;11(9). Epub 20200827. doi: 10.3390/genes11091010 ; PubMed Central PMCID: PMC7565048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11091010</ArticleId><ArticleId IdType="pmc">PMC7565048</ArticleId><ArticleId IdType="pubmed">32867305</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz JE, Kosmicki JA, Damask A, Sharma D, Roberts GHL, Justice AE, et al.. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat Genet. 2022;54(4):382–392. Epub 20220303. doi: 10.1038/s41588-021-01006-7 ; PubMed Central PMCID: PMC9005345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-01006-7</ArticleId><ArticleId IdType="pmc">PMC9005345</ArticleId><ArticleId IdType="pubmed">35241825</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Garcia A, Perez de Diego R, Flores C, Rinchai D, Sole-Violan J, Deya-Martinez A, et al.. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia. J Exp Med. 2023;220(5). Epub 20230303. doi: 10.1084/jem.20220170 ; PubMed Central PMCID: PMC9998661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220170</ArticleId><ArticleId IdType="pmc">PMC9998661</ArticleId><ArticleId IdType="pubmed">36880831</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallerini C, Daga S, Mantovani S, Benetti E, Picchiotti N, Francisci D, et al.. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. Elife. 2021;10. Epub 20210302. doi: 10.7554/eLife.67569 ; PubMed Central PMCID: PMC7987337.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67569</ArticleId><ArticleId IdType="pmc">PMC7987337</ArticleId><ArticleId IdType="pubmed">33650967</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid GG, Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, et al.. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383(16):1522–1534. Epub 20200617. doi: 10.1056/NEJMoa2020283 ; PubMed Central PMCID: PMC7315890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al.. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Hum Mol Genet. 2022;31(23):3945–3966. doi: 10.1093/hmg/ddac158 ; PubMed Central PMCID: PMC9703941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac158</ArticleId><ArticleId IdType="pmc">PMC9703941</ArticleId><ArticleId IdType="pubmed">35848942</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Antonio M, Nguyen JP, Arthur TD, Matsui H, Initiative C-HG, D’Antonio-Chronowska A, et al.. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues. Cell Rep. 2021;37(7):110020. Epub 20211103. doi: 10.1016/j.celrep.2021.110020 ; PubMed Central PMCID: PMC8563343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110020</ArticleId><ArticleId IdType="pmc">PMC8563343</ArticleId><ArticleId IdType="pubmed">34762851</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz R, Diz-de Almeida S, Lopez de Heredia M, Quintela I, Ceballos FC, Pita G, et al.. Novel genes and sex differences in COVID-19 severity. Hum Mol Genet 2022;31(22):3789–3806. doi: 10.1093/hmg/ddac132 ; PubMed Central PMCID: PMC9652109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac132</ArticleId><ArticleId IdType="pmc">PMC9652109</ArticleId><ArticleId IdType="pubmed">35708486</ArticleId></ArticleIdList></Reference><Reference><Citation>Initiative C-HG. A first update on mapping the human genetic architecture of COVID-19. Nature. 2022;608(7921):E1–E10. Epub 20220803. doi: 10.1038/s41586-022-04826-7 ; PubMed Central PMCID: PMC9352569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04826-7</ArticleId><ArticleId IdType="pmc">PMC9352569</ArticleId><ArticleId IdType="pubmed">35922517</ArticleId></ArticleIdList></Reference><Reference><Citation>Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, et al.. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience. 2021;24(4):102322. Epub 20210317. doi: 10.1016/j.isci.2021.102322 ; PubMed Central PMCID: PMC7968217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102322</ArticleId><ArticleId IdType="pmc">PMC7968217</ArticleId><ArticleId IdType="pubmed">33748697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Butler-Laporte G, Nakanishi T, Morrison DR, Afilalo J, Afilalo M, et al.. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021;27(4):659–667. Epub 20210225. doi: 10.1038/s41591-021-01281-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01281-1</ArticleId><ArticleId IdType="pubmed">33633408</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman JE, Butler-Laporte G, Khan A, Pairo-Castineira E, Drivas TG, Peloso GM, et al.. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. Nat Genet. 2022;54(2):125–127. Epub 20220113. doi: 10.1038/s41588-021-00996-8 ; PubMed Central PMCID: PMC8837537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00996-8</ArticleId><ArticleId IdType="pmc">PMC8837537</ArticleId><ArticleId IdType="pubmed">35027740</ArticleId></ArticleIdList></Reference><Reference><Citation>Initiative C-HG. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472–477. Epub 20210708. doi: 10.1038/s41586-021-03767-x ; PubMed Central PMCID: PMC8674144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03767-x</ArticleId><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al.. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591(7848):92–98. Epub 20201211. doi: 10.1038/s41586-020-03065-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03065-y</ArticleId><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Banday AR, Stanifer ML, Florez-Vargas O, Onabajo OO, Papenberg BW, Zahoor MA, et al.. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat Genet. 2022;54(8):1103–1116. Epub 20220714. doi: 10.1038/s41588-022-01113-z ; PubMed Central PMCID: PMC9355882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01113-z</ArticleId><ArticleId IdType="pmc">PMC9355882</ArticleId><ArticleId IdType="pubmed">35835913</ArticleId></ArticleIdList></Reference><Reference><Citation>Payman S-T, Hala A, James DRK, Audrey A, Reuben S, Zhen-Yuan L, et al.. A SARS-CoV-2 – host proximity interactome. bioRxiv [Preprint]. 2020:2020.09.03.282103. doi: 10.1101/2020.09.03.282103</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.03.282103</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al.. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–468. Epub 20200430. doi: 10.1038/s41586-020-2286-9 ; PubMed Central PMCID: PMC7431030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Estelle MNL, Yorgos S, Anastassia K, Jean-Pascal G, Payman Samavarchi T, Dae-Kyum K, et al.. Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms. bioRxiv [Preprint]. 2020:2020.08.28.272955. doi: 10.1101/2020.08.28.272955</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.28.272955</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Germain JR, Astori A, Samavarchi-Tehrani P, Abdouni H, Macwan V, Kim D-K, et al.. A SARS-CoV-2 BioID-based virus-host membrane protein interactome and virus peptide compendium: new proteomics resources for COVID-19 research. bioRxiv [Preprint]. 2020:2020.08.28.269175. doi: 10.1101/2020.08.28.269175</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.28.269175</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Huuskonen S, Laitinen T, Redchuk T, Bogacheva M, Salokas K, et al.. SARS-CoV-2-host proteome interactions for antiviral drug discovery. Mol Syst Biol. 2021;17(11):e10396. doi: 10.15252/msb.202110396 ; PubMed Central PMCID: PMC8552907.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110396</ArticleId><ArticleId IdType="pmc">PMC8552907</ArticleId><ArticleId IdType="pubmed">34709727</ArticleId></ArticleIdList></Reference><Reference><Citation>May DG, Martin-Sancho L, Anschau V, Liu S, Chrisopulos RJ, Scott KL, et al.. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. Viruses. 2022;14(3). Epub 20220315. doi: 10.3390/v14030611 ; PubMed Central PMCID: PMC8951556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030611</ArticleId><ArticleId IdType="pmc">PMC8951556</ArticleId><ArticleId IdType="pubmed">35337019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu Y, Gupta S, Paramo MI, Hou Y, Mao C, et al.. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Nat Biotechnol. 2023;41(1):128–139. Epub 20221010. doi: 10.1038/s41587-022-01474-0 ; PubMed Central PMCID: PMC9851973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01474-0</ArticleId><ArticleId IdType="pmc">PMC9851973</ArticleId><ArticleId IdType="pubmed">36217030</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukalov A, Girault V, Grass V, Karayel O, Bergant V, Urban C, et al.. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021;594(7862):246–252. Epub 20210412. doi: 10.1038/s41586-021-03493-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03493-4</ArticleId><ArticleId IdType="pubmed">33845483</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Guo M, Tian X, Wang X, Yang X, Wu P, et al.. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. Fortschr Med. 2021;2(1):99–112 e7. Epub 20200721. doi: 10.1016/j.medj.2020.07.002 ; PubMed Central PMCID: PMC7373048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7373048</ArticleId><ArticleId IdType="pubmed">32838362</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies JP, Almasy KM, McDonald EF, Plate L. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies. ACS Infect Dis. 2020;6(12):3174–3189. Epub 20201202. doi: 10.1021/acsinfecdis.0c00500 ; PubMed Central PMCID: PMC7724760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00500</ArticleId><ArticleId IdType="pmc">PMC7724760</ArticleId><ArticleId IdType="pubmed">33263384</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N, Ganskih S, Wei Y, Gabel A, Zielinski S, Keshishian H, et al.. SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. Cell. 2023;186(22):4834–4850 e23. Epub 20231003. doi: 10.1016/j.cell.2023.09.002 ; PubMed Central PMCID: PMC10617981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.002</ArticleId><ArticleId IdType="pmc">PMC10617981</ArticleId><ArticleId IdType="pubmed">37794589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N, Lareau CA, Keshishian H, Ganskih S, Schneider C, Hennig T, et al.. The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat Microbiol. 2021;6(3):339–353. Epub 20201221. doi: 10.1038/s41564-020-00846-z ; PubMed Central PMCID: PMC7906908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00846-z</ArticleId><ArticleId IdType="pmc">PMC7906908</ArticleId><ArticleId IdType="pubmed">33349665</ArticleId></ArticleIdList></Reference><Reference><Citation>Labeau A, Fery-Simonian L, Lefevre-Utile A, Pourcelot M, Bonnet-Madin L, Soumelis V, et al.. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome. Cell Rep. 2022;39(4):110744. doi: 10.1016/j.celrep.2022.110744 ; PubMed Central PMCID: PMC9040432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110744</ArticleId><ArticleId IdType="pmc">PMC9040432</ArticleId><ArticleId IdType="pubmed">35477000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel W, Noerenberg M, Cerikan B, Chen H, Jarvelin AI, Kammoun M, et al.. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection. Mol Cell. 2021;81(13):2851–2867 e7. Epub 20210524. doi: 10.1016/j.molcel.2021.05.023 ; PubMed Central PMCID: PMC8142890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.05.023</ArticleId><ArticleId IdType="pmc">PMC8142890</ArticleId><ArticleId IdType="pubmed">34118193</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn RA, Belk JA, Qi Y, Yasumoto Y, Wei J, Alfajaro MM, et al.. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions. Cell. 2021;184(9):2394–2411 e16. Epub 20210311. doi: 10.1016/j.cell.2021.03.012 ; PubMed Central PMCID: PMC7951565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC7951565</ArticleId><ArticleId IdType="pubmed">33743211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Lee YS, Choi Y, Son A, Park Y, Lee KM, et al.. The SARS-CoV-2 RNA interactome. Mol Cell. 2021;81(13):2838–2850 e6. Epub 20210427. doi: 10.1016/j.molcel.2021.04.022 ; PubMed Central PMCID: PMC8075806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.04.022</ArticleId><ArticleId IdType="pmc">PMC8075806</ArticleId><ArticleId IdType="pubmed">33989516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al.. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020;182(3):685–712 e19. Epub 20200628. doi: 10.1016/j.cell.2020.06.034 ; PubMed Central PMCID: PMC7321036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Magraner L, Posada IM, Andraka N, Contreras FX, Viguera AR, Guerin DM, et al.. The C-terminal transmembrane domain of human phospholipid scramblase 1 is essential for the protein flip-flop activity and Ca(2)(+)-binding. J Membr Biol. 2014;247(2):155–165. Epub 20131217. doi: 10.1007/s00232-013-9619-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00232-013-9619-7</ArticleId><ArticleId IdType="pubmed">24343571</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla S, Aevermann B, Assis P, Badajoz S, Bell SM, Bezzi E, et al.. CZ CELL×GENE Discover: A single-cell data platform for scalable exploration, analysis and modeling of aggregated data. bioRxiv [Preprint]. 2023:2023.10.30.563174. doi: 10.1101/2023.10.30.563174</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.10.30.563174</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricardo-Lax I, Luna JM, Thao TTN, Le Pen J, Yu Y, Hoffmann HH, et al.. Replication and single-cycle delivery of SARS-CoV-2 replicons. Science. 2021;374(6571):1099–1106. Epub 20211014. doi: 10.1126/science.abj8430 ; PubMed Central PMCID: PMC9007107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8430</ArticleId><ArticleId IdType="pmc">PMC9007107</ArticleId><ArticleId IdType="pubmed">34648371</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, et al.. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020;217(11). doi: 10.1084/jem.20201181 ; PubMed Central PMCID: PMC7372514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201181</ArticleId><ArticleId IdType="pmc">PMC7372514</ArticleId><ArticleId IdType="pubmed">32692348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaender S, Mar KB, Michailidis E, Kratzel A, Boys IN, V’Kovski P, et al.. LY6E impairs coronavirus fusion and confers immune control of viral disease. Nat Microbiol. 2020;5(11):1330–1339. Epub 20200723. doi: 10.1038/s41564-020-0769-y ; PubMed Central PMCID: PMC7916999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0769-y</ArticleId><ArticleId IdType="pmc">PMC7916999</ArticleId><ArticleId IdType="pubmed">32704094</ArticleId></ArticleIdList></Reference><Reference><Citation>Winstone H, Lista MJ, Reid AC, Bouton C, Pickering S, Galao RP, et al.. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2. J Virol. 2021;95(9). Epub 20210412. doi: 10.1128/JVI.02422-20 ; PubMed Central PMCID: PMC8104117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02422-20</ArticleId><ArticleId IdType="pmc">PMC8104117</ArticleId><ArticleId IdType="pubmed">33563656</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne LG, Bouhaddou M, Reuschl AK, Zuliani-Alvarez L, Polacco B, Pelin A, et al.. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2022;602(7897):487–495. Epub 20211223. doi: 10.1038/s41586-021-04352-y ; PubMed Central PMCID: PMC8850198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04352-y</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, et al.. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21(6):361–379. doi: 10.1038/s41579-023-00878-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, de Silva TI, et al.. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162–177. doi: 10.1038/s41579-022-00841-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Liao R, Chen X, Wu X, Li X, Wang Y, et al.. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer. Theranostics. 2020;10(10):4644–4658. Epub 20200325. doi: 10.7150/thno.43150 ; PubMed Central PMCID: PMC7150476.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.43150</ArticleId><ArticleId IdType="pmc">PMC7150476</ArticleId><ArticleId IdType="pubmed">32292520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanjundan M, Sun J, Zhao J, Zhou Q, Sims PJ, Wiedmer T. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor. J Biol Chem. 2003;278(39):37413–37418. Epub 20030718. doi: 10.1074/jbc.M306182200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M306182200</ArticleId><ArticleId IdType="pubmed">12871937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Efraim I, Zhou Q, Wiedmer T, Gerace L, Sims PJ. Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. Biochemistry. 2004;43(12):3518–3526. doi: 10.1021/bi0356911 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0356911</ArticleId><ArticleId IdType="pubmed">15035622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MH, Ben-Efraim I, Mitrousis G, Walker-Kopp N, Sims PJ, Cingolani G. Phospholipid scramblase 1 contains a nonclassical nuclear localization signal with unique binding site in importin alpha. J Biol Chem. 2005;280(11):10599–10606. Epub 20041217. doi: 10.1074/jbc.M413194200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M413194200</ArticleId><ArticleId IdType="pubmed">15611084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedmer T, Zhao J, Nanjundan M, Sims PJ. Palmitoylation of phospholipid scramblase 1 controls its distribution between nucleus and plasma membrane. Biochemistry. 2003;42(5):1227–1233. doi: 10.1021/bi026679w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi026679w</ArticleId><ArticleId IdType="pubmed">12564925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhou Q, Wiedmer T, Sims PJ. Palmitoylation of phospholipid scramblase is required for normal function in promoting Ca2+-activated transbilayer movement of membrane phospholipids. Biochemistry. 1998;37(18):6361–6366. doi: 10.1021/bi980218m .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi980218m</ArticleId><ArticleId IdType="pubmed">9572851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al.. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625(7993):92–100. doi: 10.1038/s41586-023-06045-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06045-0</ArticleId><ArticleId IdType="pubmed">38057664</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Bigio B, Rapaport F, Zhang SY, Casanova JL, Abel L, et al.. PopViz: a webserver for visualizing minor allele frequencies and damage prediction scores of human genetic variations. Bioinformatics. 2018;34(24):4307–4309. doi: 10.1093/bioinformatics/bty536 ; PubMed Central PMCID: PMC6289133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty536</ArticleId><ArticleId IdType="pmc">PMC6289133</ArticleId><ArticleId IdType="pubmed">30535305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmann M, Hoffmann HH, Scull MA, Gilmore RH, Bell KL, Ciancanelli M, et al.. A serpin shapes the extracellular environment to prevent influenza A virus maturation. Cell. 2015;160(4):631–643. doi: 10.1016/j.cell.2015.01.040 ; PubMed Central PMCID: PMC4328142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.040</ArticleId><ArticleId IdType="pmc">PMC4328142</ArticleId><ArticleId IdType="pubmed">25679759</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke JM, St Clair LA, Perera R, Parker R. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block. RNA. 2021;27(11):1318–1329. Epub 20210727. doi: 10.1261/rna.078923.121 ; PubMed Central PMCID: PMC8522697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.078923.121</ArticleId><ArticleId IdType="pmc">PMC8522697</ArticleId><ArticleId IdType="pubmed">34315815</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Miorin L, Makio T, Dehghan I, Gao S, Xie Y, et al.. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Sci Adv. 2021;7(6). Epub 20210205. doi: 10.1126/sciadv.abe7386 ; PubMed Central PMCID: PMC7864571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe7386</ArticleId><ArticleId IdType="pmc">PMC7864571</ArticleId><ArticleId IdType="pubmed">33547084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura I, Konno Y, Uriu K, Hopfensperger K, Sauter D, Nakagawa S, et al.. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Rep. 2021;34(13):108916. Epub 20210312. doi: 10.1016/j.celrep.2021.108916 ; PubMed Central PMCID: PMC7953434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108916</ArticleId><ArticleId IdType="pmc">PMC7953434</ArticleId><ArticleId IdType="pubmed">33765414</ArticleId></ArticleIdList></Reference><Reference><Citation>Setaro AC, Gaglia MM. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. Curr Res Virol Sci. 2021;2:100015. Epub 20211112. doi: 10.1016/j.crviro.2021.100015 ; PubMed Central PMCID: PMC8588586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crviro.2021.100015</ArticleId><ArticleId IdType="pmc">PMC8588586</ArticleId><ArticleId IdType="pubmed">34786565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunjimi B, Zhang SY, Sorensen KB, Skipper KA, Carter-Timofte M, Kerner G, et al.. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest. 2017;127(9):3543–3556. Epub 20170807. doi: 10.1172/JCI92280 ; PubMed Central PMCID: PMC5669568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI92280</ArticleId><ArticleId IdType="pmc">PMC5669568</ArticleId><ArticleId IdType="pubmed">28783042</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer MM, Kibe A, Rand U, Pekarek L, Ye L, Buck S, et al.. The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting. Nat Commun. 2021;12(1):7193. Epub 20211210. doi: 10.1038/s41467-021-27431-0 ; PubMed Central PMCID: PMC8664833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27431-0</ArticleId><ArticleId IdType="pmc">PMC8664833</ArticleId><ArticleId IdType="pubmed">34893599</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein S, Golani G, Lolicato F, Lahr C, Beyer D, Herrmann A, et al.. IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusion. Cell Host Microbe. 2023. Epub 20230329. doi: 10.1016/j.chom.2023.03.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2023.03.005</ArticleId><ArticleId IdType="pubmed">37003257</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Steinkuhler J, Marin M, Li X, Lu W, Dimova R, et al.. Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Altering Mechanical Properties of Cell Membranes. ACS Nano. 2021;15(5):8155–8170. Epub 20210303. doi: 10.1021/acsnano.0c10567 ; PubMed Central PMCID: PMC8159881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.0c10567</ArticleId><ArticleId IdType="pmc">PMC8159881</ArticleId><ArticleId IdType="pubmed">33656312</ArticleId></ArticleIdList></Reference><Reference><Citation>Suddala KC, Lee CC, Meraner P, Marin M, Markosyan RM, Desai TM, et al.. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes. PLoS Pathog. 2019;15(1):e1007532. Epub 20190114. doi: 10.1371/journal.ppat.1007532 ; PubMed Central PMCID: PMC6347298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007532</ArticleId><ArticleId IdType="pmc">PMC6347298</ArticleId><ArticleId IdType="pubmed">30640957</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog. 2014;10(4):e1004048. Epub 20140403. doi: 10.1371/journal.ppat.1004048 ; PubMed Central PMCID: PMC3974867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004048</ArticleId><ArticleId IdType="pmc">PMC3974867</ArticleId><ArticleId IdType="pubmed">24699674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadeel B, Gleiss B, Hogstrand K, Chandra J, Wiedmer T, Sims PJ, et al.. Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun. 1999;266(2):504–511. doi: 10.1006/bbrc.1999.1820 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.1820</ArticleId><ArticleId IdType="pubmed">10600532</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Zhao J, Al-Zoghaibi F, Zhou A, Wiedmer T, Silverman RH, et al.. Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha. Blood. 2000;95(8):2593–2599. PubMed .</Citation><ArticleIdList><ArticleId IdType="pubmed">10753839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Zhao J, Wiedmer T, Sims PJ. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood. 2002;99(11):4030–4038. doi: 10.1182/blood-2001-12-0271 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2001-12-0271</ArticleId><ArticleId IdType="pubmed">12010804</ArticleId></ArticleIdList></Reference><Reference><Citation>Majdoul S, Compton AA. Lessons in self-defence: inhibition of virus entry by intrinsic immunity. Nat Rev Immunol. 2022;22(6):339–352. Epub 20211013. doi: 10.1038/s41577-021-00626-8 ; PubMed Central PMCID: PMC8511856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00626-8</ArticleId><ArticleId IdType="pmc">PMC8511856</ArticleId><ArticleId IdType="pubmed">34646033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano S, Eizuru Y. Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax. Virology. 2012;432(2):343–352. Epub 20120711. doi: 10.1016/j.virol.2012.06.019 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.06.019</ArticleId><ArticleId IdType="pubmed">22789739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano S, Eizuru Y. Interaction of the phospholipid scramblase 1 with HIV-1 Tat results in the repression of Tat-dependent transcription. Biochem Biophys Res Commun. 2013;433(4):438–444. Epub 20130315. doi: 10.1016/j.bbrc.2013.02.098 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.02.098</ArticleId><ArticleId IdType="pubmed">23501106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadanari H, Takemoto M, Ishida T, Otagiri H, Daikoku T, Murayama T, et al.. The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus. Microbiol Spectr. 2022;10(1):e0134221. Epub 2022/02/10. doi: 10.1128/spectrum.01342-21 ; PubMed Central PMCID: PMC8826943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01342-21</ArticleId><ArticleId IdType="pmc">PMC8826943</ArticleId><ArticleId IdType="pubmed">35138119</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, et al.. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology. 2012;56(6):2082–2093. Epub 20121014. doi: 10.1002/hep.25908 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.25908</ArticleId><ArticleId IdType="pubmed">22711689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhu X, Liu J, Ding X, Han M, Hu W, et al.. Inhibition of Hepatitis B virus replication by phospholipid scramblase 1 in vitro and in vivo. Antiviral Res. 2012;94(1):9–17. Epub 20120209. doi: 10.1016/j.antiviral.2012.01.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.01.010</ArticleId><ArticleId IdType="pubmed">22342889</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano S, Ikeda M. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription. J Biol Chem. 2019;294(41):15104–15116. Epub 2019/08/23. doi: 10.1074/jbc.RA119.008193 ; PubMed Central PMCID: PMC6791327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.008193</ArticleId><ArticleId IdType="pmc">PMC6791327</ArticleId><ArticleId IdType="pubmed">31434743</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Zhang J, Liang L, Wang G, Li Q, Zhu P, et al.. Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication. PLoS Pathog. 2018;14(1):e1006851. Epub 20180119. doi: 10.1371/journal.ppat.1006851 ; PubMed Central PMCID: PMC5792031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006851</ArticleId><ArticleId IdType="pmc">PMC5792031</ArticleId><ArticleId IdType="pubmed">29352288</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Col J, Lamberti MJ, Nigro A, Casolaro V, Fratta E, Steffan A, et al.. Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors. Cell Commun Signal. 2022;20(1):78. Epub 2022/06/02. doi: 10.1186/s12964-022-00895-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-022-00895-3</ArticleId><ArticleId IdType="pmc">PMC9158361</ArticleId><ArticleId IdType="pubmed">35650588</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo K, Barrett BS, Morrison JH, Mickens KL, Vladar EK, Hasenkrug KJ, et al.. Interferon resistance of emerging SARS-CoV-2 variants. Proc Natl Acad Sci U S A. 2022;119(32):e2203760119. Epub 20220722. doi: 10.1073/pnas.2203760119 ; PubMed Central PMCID: PMC9371743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2203760119</ArticleId><ArticleId IdType="pmc">PMC9371743</ArticleId><ArticleId IdType="pubmed">35867811</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalamova L, Felgenhauer U, Wilhelm J, Schaubmar AR, Buttner K, Schoen A, et al.. Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response. PNAS Nexus. 2022;1(2):pgac067. Epub 20220523. doi: 10.1093/pnasnexus/pgac067 ; PubMed Central PMCID: PMC9802332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgac067</ArticleId><ArticleId IdType="pmc">PMC9802332</ArticleId><ArticleId IdType="pubmed">36713328</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi G, Li T, Lai KK, Johnson RF, Yewdell JW, Compton AA. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. Nat Commun. 2024;15(1):889. Epub 20240130. doi: 10.1038/s41467-024-45075-8 ; PubMed Central PMCID: PMC10828397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-45075-8</ArticleId><ArticleId IdType="pmc">PMC10828397</ArticleId><ArticleId IdType="pubmed">38291024</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle T, Moncorge O, Bonaventure B, Pollpeter D, Lussignol M, Tauziet M, et al.. The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry. Nat Microbiol. 2018;3(12):1369–1376. Epub 20181126. doi: 10.1038/s41564-018-0273-9 ; PubMed Central PMCID: PMC6329445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0273-9</ArticleId><ArticleId IdType="pmc">PMC6329445</ArticleId><ArticleId IdType="pubmed">30478388</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H, Winstone H, Jimenez-Guardeno JM, Graham C, Doores KJ, Goujon C, et al.. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathog. 2021;17(11):e1009820. Epub 20211122. doi: 10.1371/journal.ppat.1009820 ; PubMed Central PMCID: PMC8648102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009820</ArticleId><ArticleId IdType="pmc">PMC8648102</ArticleId><ArticleId IdType="pubmed">34807954</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, et al.. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7(8):1161–1179. Epub 20220707. doi: 10.1038/s41564-022-01143-7 ; PubMed Central PMCID: PMC9352574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01143-7</ArticleId><ArticleId IdType="pmc">PMC9352574</ArticleId><ArticleId IdType="pubmed">35798890</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock TP, Brown JC, Zhou J, Thakur N, Sukhova K, Newman J, et al.. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein. bioRxiv [Preprint]. 2022:2021.12.31.474653. doi: 10.1101/2021.12.31.474653</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.31.474653</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai H, Chan JF, Hu B, Chai Y, Yuen TT, Yin F, et al.. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603(7902):693–699. Epub 20220121. doi: 10.1038/s41586-022-04442-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04442-5</ArticleId><ArticleId IdType="pubmed">35062016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui KPY, Ho JCW, Cheung MC, Ng KC, Ching RHH, Lai KL, et al.. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715–720. Epub 20220201. doi: 10.1038/s41586-022-04479-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04479-6</ArticleId><ArticleId IdType="pubmed">35104836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Lu L, Peng Z, Chen LL, Meng X, Zhang C, et al.. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect. 2022;11(1):277–283. doi: 10.1080/22221751.2021.2023329 ; PubMed Central PMCID: PMC8774049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2023329</ArticleId><ArticleId IdType="pmc">PMC8774049</ArticleId><ArticleId IdType="pubmed">34951565</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B, Abdullahi A, Ferreira I, Goonawardane N, Saito A, Kimura I, et al.. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603(7902):706–714. Epub 20220201. doi: 10.1038/s41586-022-04474-x ; PubMed Central PMCID: PMC8942856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04474-x</ArticleId><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141. Epub 20220428. doi: 10.1038/s41392-022-00997-x ; PubMed Central PMCID: PMC9047469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00997-x</ArticleId><ArticleId IdType="pmc">PMC9047469</ArticleId><ArticleId IdType="pubmed">35484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–880. Epub 20210112. doi: 10.1016/j.cell.2021.01.007 ; PubMed Central PMCID: PMC7803150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar KB, Van Dyke MC, Lopez AH, Eitson JL, Fan W, Hanners NW, et al.. LY6E protects mice from pathogenic effects of murine coronavirus and SARS-CoV-2. bioRxiv [Preprint]. 2023. Epub 20230126. doi: 10.1101/2023.01.25.525551 ; PubMed Central PMCID: PMC9900800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.25.525551</ArticleId><ArticleId IdType="pmc">PMC9900800</ArticleId><ArticleId IdType="pubmed">36747632</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580–585. doi: 10.1038/ng.2653 ; PubMed Central PMCID: PMC4010069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2653</ArticleId><ArticleId IdType="pmc">PMC4010069</ArticleId><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76(24):13001–13014. doi: 10.1128/jvi.76.24.13001-13014.2002 ; PubMed Central PMCID: PMC136668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.24.13001-13014.2002</ArticleId><ArticleId IdType="pmc">PMC136668</ArticleId><ArticleId IdType="pubmed">12438626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainou BA, Zamora PF, Ashbrook AW, Dorset DC, Kim KS, Dermody TS. Reovirus cell entry requires functional microtubules. mBio. 2013; 4(4):e00405–13. doi: 10.1128/mBio.00405-13 ; PubMed Central PMCID: PMC3705452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00405-13</ArticleId><ArticleId IdType="pmc">PMC3705452</ArticleId><ArticleId IdType="pubmed">23820395</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitt NH, Ramsburg HH, Hasty SE, Repik PM, Cole FE Jr, Lupton HW. Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine. 1986;4(3):157–162. doi: 10.1016/0264-410x(86)90003-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0264-410x(86)90003-4</ArticleId><ArticleId IdType="pubmed">3020820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, et al.. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol. 2005;79(2):1113–1124. doi: 10.1128/JVI.79.2.1113-1124.2005 ; PubMed Central PMCID: PMC538579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.1113-1124.2005</ArticleId><ArticleId IdType="pmc">PMC538579</ArticleId><ArticleId IdType="pubmed">15613339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann HH, Schneider WM, Rozen-Gagnon K, Miles LA, Schuster F, Razooky B, et al.. TMEM41B Is a Pan-flavivirus Host Factor. Cell. 2021;184(1):133–148 e20. Epub 20201209. doi: 10.1016/j.cell.2020.12.005 ; PubMed Central PMCID: PMC7954666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7954666</ArticleId><ArticleId IdType="pubmed">33338421</ArticleId></ArticleIdList></Reference><Reference><Citation>Benboudjema L, Mulvey M, Gao Y, Pimplikar SW, Mohr I. Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light-chain-related protein PAT1 results in the redistribution of both polypeptides. J Virol. 2003;77(17):9192–9203. doi: 10.1128/jvi.77.17.9192-9203.2003 ; PubMed Central PMCID: PMC187382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.17.9192-9203.2003</ArticleId><ArticleId IdType="pmc">PMC187382</ArticleId><ArticleId IdType="pubmed">12915535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, et al.. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science. 2023;379(6632):eabo3627. Epub 20230210. doi: 10.1126/science.abo3627 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo3627</ArticleId><ArticleId IdType="pmc">PMC10451000</ArticleId><ArticleId IdType="pubmed">36538032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza EJ, Manguiat K, Wood H, Drebot M. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2. Curr Protoc Microbiol. 2020;57(1):ecpmc105. doi: 10.1002/cpmc.105 ; PubMed Central PMCID: PMC7300432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpmc.105</ArticleId><ArticleId IdType="pmc">PMC7300432</ArticleId><ArticleId IdType="pubmed">32475066</ArticleId></ArticleIdList></Reference><Reference><Citation>Polo JM, Davis NL, Rice CM, Huang HV, Johnston RE. Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro. J Virol. 1988;62(6):2124–2133. doi: 10.1128/JVI.62.6.2124-2133.1988 ; PubMed Central PMCID: PMC253309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.62.6.2124-2133.1988</ArticleId><ArticleId IdType="pmc">PMC253309</ArticleId><ArticleId IdType="pubmed">2835514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bick MJ, Carroll JW, Gao G, Goff SP, Rice CM, MacDonald MR. Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol. 2003;77(21):11555–11562. doi: 10.1128/jvi.77.21.11555-11562.2003 ; PubMed Central PMCID: PMC229374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.21.11555-11562.2003</ArticleId><ArticleId IdType="pmc">PMC229374</ArticleId><ArticleId IdType="pubmed">14557641</ArticleId></ArticleIdList></Reference><Reference><Citation>Atasheva S, Kim DY, Akhrymuk M, Morgan DG, Frolova EI, Frolov I. Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation. J Virol. 2013;87(4):2023–2035. Epub 20121205. doi: 10.1128/JVI.02881-12 ; PubMed Central PMCID: PMC3571482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02881-12</ArticleId><ArticleId IdType="pmc">PMC3571482</ArticleId><ArticleId IdType="pubmed">23221545</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton KP, Rose JK. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology. 2001;279(2):414–421. doi: 10.1006/viro.2000.0736 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0736</ArticleId><ArticleId IdType="pubmed">11162797</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al.. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. Epub 20121025. doi: 10.1093/bioinformatics/bts635 ; PubMed Central PMCID: PMC3530905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8):e47. doi: 10.1093/nar/gkz114 ; PubMed Central PMCID: PMC6486549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz114</ArticleId><ArticleId IdType="pmc">PMC6486549</ArticleId><ArticleId IdType="pubmed">30783653</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8 ; PubMed Central PMCID: PMC4302049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. bioRxiv [Preprint]. 2021:060012. doi: 10.1101/060012</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/060012</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739–1740. Epub 20110505. doi: 10.1093/bioinformatics/btr260 ; PubMed Central PMCID: PMC3106198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr260</ArticleId><ArticleId IdType="pmc">PMC3106198</ArticleId><ArticleId IdType="pubmed">21546393</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, et al.. The Reactome Pathway Knowledgebase. Nucleic Acids Res. 2018;46(D1):D649–D655. doi: 10.1093/nar/gkx1132 ; PubMed Central PMCID: PMC5753187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1132</ArticleId><ArticleId IdType="pmc">PMC5753187</ArticleId><ArticleId IdType="pubmed">29145629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. doi: 10.1093/nar/28.1.27 ; PubMed Central PMCID: PMC102409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A, Balci H, Hanspers K, Coort SL, Martens M, Slenter DN, et al.. WikiPathways 2024: next generation pathway database. Nucleic Acids Res. 2024;52(D1):D679–D689. doi: 10.1093/nar/gkad960 ; PubMed Central PMCID: PMC10767877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad960</ArticleId><ArticleId IdType="pmc">PMC10767877</ArticleId><ArticleId IdType="pubmed">37941138</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, et al.. PID: the Pathway Interaction Database. Nucleic Acids Res. 2009;37(Database issue):D674–D679. Epub 20081002. doi: 10.1093/nar/gkn653 ; PubMed Central PMCID: PMC2686461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn653</ArticleId><ArticleId IdType="pmc">PMC2686461</ArticleId><ArticleId IdType="pubmed">18832364</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura D. BioCarta. Biotech Software &amp; Internet Report: The Computer Software Journal for Scient. 2001;2(3):117–120.</Citation></Reference><Reference><Citation>Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. doi: 10.1038/nprot.2008.73 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.73</ArticleId><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Witte L, Baharani VA, Schmidt F, Wang Z, Cho A, Raspe R, et al.. Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape. Nat Commun. 2023;14(1):302. Epub 20230119. doi: 10.1038/s41467-023-35927-0 ; PubMed Central PMCID: PMC9849103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-35927-0</ArticleId><ArticleId IdType="pmc">PMC9849103</ArticleId><ArticleId IdType="pubmed">36653360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Muecksch F, Raspe R, Johannsen F, Turroja M, Canis M, et al.. Memory B cell development elicited by mRNA booster vaccinations in the elderly. J Exp Med. 2023;220(9). Epub 20230627. doi: 10.1084/jem.20230668 ; PubMed Central PMCID: PMC10300432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20230668</ArticleId><ArticleId IdType="pmc">PMC10300432</ArticleId><ArticleId IdType="pubmed">37368240</ArticleId></ArticleIdList></Reference><Reference><Citation>UniProt C. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523–D531. doi: 10.1093/nar/gkac1052 ; PubMed Central PMCID: PMC9825514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1052</ArticleId><ArticleId IdType="pmc">PMC9825514</ArticleId><ArticleId IdType="pubmed">36408920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruchez A, Sha K, Johnson J, Chen L, Stefani C, McConnell H, et al.. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science. 2020;370(6513):241–247. Epub 20200827. doi: 10.1126/science.abb3753 ; PubMed Central PMCID: PMC7665841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3753</ArticleId><ArticleId IdType="pmc">PMC7665841</ArticleId><ArticleId IdType="pubmed">32855215</ArticleId></ArticleIdList></Reference><Reference><Citation>Lista MJ, Winstone H, Wilson HD, Dyer A, Pickering S, Galao RP, et al.. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance. J Virol. 2022;96(23):e0125022. Epub 20221109. doi: 10.1128/jvi.01250-22 ; PubMed Central PMCID: PMC9749455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01250-22</ArticleId><ArticleId IdType="pmc">PMC9749455</ArticleId><ArticleId IdType="pubmed">36350154</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi G, Kenney AD, Kudryashova E, Zani A, Zhang L, Lai KK, et al.. Opposing activities of IFITM proteins in SARS-CoV-2 infection. EMBO J. 2021;40(3):e106501. Epub 20201221. doi: 10.15252/embj.2020106501 ; PubMed Central PMCID: PMC7744865.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106501</ArticleId><ArticleId IdType="pmc">PMC7744865</ArticleId><ArticleId IdType="pubmed">33270927</ArticleId></ArticleIdList></Reference><Reference><Citation>Prelli Bozzo C, Nchioua R, Volcic M, Koepke L, Kruger J, Schutz D, et al.. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021;12(1):4584. Epub 20210728. doi: 10.1038/s41467-021-24817-y ; PubMed Central PMCID: PMC8319209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24817-y</ArticleId><ArticleId IdType="pmc">PMC8319209</ArticleId><ArticleId IdType="pubmed">34321474</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock TP, Goldhill DH, Zhou J, Baillon L, Frise R, Swann OC, et al.. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol. 2021;6(7):899–909. Epub 20210427. doi: 10.1038/s41564-021-00908-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00908-w</ArticleId><ArticleId IdType="pubmed">33907312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nchioua R, Schundner A, Kmiec D, Prelli Bozzo C, Zech F, Koepke L, et al.. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells. J Virol. 2022;96(11):e0059422. Epub 20220511. doi: 10.1128/jvi.00594-22 ; PubMed Central PMCID: PMC9175628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00594-22</ArticleId><ArticleId IdType="pmc">PMC9175628</ArticleId><ArticleId IdType="pubmed">35543509</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Wang G, Zhao F, Huang Y, Fan Z, Mei S, et al.. IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility. Viruses. 2022;14(11). Epub 20221118. doi: 10.3390/v14112553 ; PubMed Central PMCID: PMC9692367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112553</ArticleId><ArticleId IdType="pmc">PMC9692367</ArticleId><ArticleId IdType="pubmed">36423162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi G, Chiramel AI, Li T, Lai KK, Kenney AD, Zani A, et al.. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. J Clin Invest. 2022;132(24). Epub 20221215. doi: 10.1172/JCI160766 ; PubMed Central PMCID: PMC9753997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI160766</ArticleId><ArticleId IdType="pmc">PMC9753997</ArticleId><ArticleId IdType="pubmed">36264642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney AD, Zani A, Kawahara J, Eddy AC, Wang XL, Mahesh KC, et al.. Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice. EMBO Rep. 2023;24(4):e56660. Epub 20230307. doi: 10.15252/embr.202256660 ; PubMed Central PMCID: PMC10074051.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202256660</ArticleId><ArticleId IdType="pmc">PMC10074051</ArticleId><ArticleId IdType="pubmed">36880581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieson T, Franken H, Kosinski J, Kurzawa N, Zinn N, Sweetman G, et al.. Systematic analysis of protein turnover in primary cells. Nat Commun. 2018;9(1):689. Epub 2018/02/17. doi: 10.1038/s41467-018-03106-1 ; PubMed Central PMCID: PMC5814408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03106-1</ArticleId><ArticleId IdType="pmc">PMC5814408</ArticleId><ArticleId IdType="pubmed">29449567</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al.. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–D646. doi: 10.1093/nar/gkac1000 ; PubMed Central PMCID: PMC9825434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1000</ArticleId><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>